{
  "publisher": {
    "value": [
      "BioMed Central Ltd"
    ]
  },
  "journal": {
    "value": [
      "Trials"
    ]
  },
  "title": {
    "value": [
      "Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials"
    ]
  },
  "authors": {
    "value": [
      "Boris Campillo-Gimenez",
      "Camille Buscail",
      "Oussama Zekri",
      "Brigitte Laguerre",
      "Elisabeth Le Prisé",
      "Renaud De Crevoisier",
      "Marc Cuggia"
    ]
  },
  "date": {
    "value": [
      "2015-01-16"
    ]
  },
  "doi": {
    "value": [
      "10.1186/s13063-014-0535-7"
    ]
  },
  "volume": {
    "value": [
      "16"
    ]
  },
  "issue": {
    "value": [
      "1"
    ]
  },
  "firstpage": {
    "value": [
      "15"
    ]
  },
  "description": {
    "value": [
      "The performance of randomized controlled trials (RCTs) is often hindered by recruitment difficulties. This study aims to explore the pre-screening phase of four prostate cancer RCTs to identify the impact of a systematic pre-selection of eligible patients for RCT recruitment."
    ]
  },
  "abstract": {
    "value": [
      "The performance of randomized controlled trials (RCTs) is often hindered by recruitment difficulties. This study aims to explore the pre-screening phase of four prostate cancer RCTs to identify the impact of a systematic pre-selection of eligible patients for RCT recruitment."
    ]
  },
  "fulltext_html": {
    "value": [
      "http://www.trialsjournal.com/content/16/1/15"
    ]
  },
  "fulltext_pdf": {
    "value": [
      "http://www.trialsjournal.com/content/pdf/s13063-014-0535-7.pdf"
    ]
  },
  "fulltext_xml": {
    "value": [
      "/content/download/xml/s13063-014-0535-7.xml"
    ]
  },
  "supplementary_material": {
    "value": []
  },
  "figure": {
    "value": [
      "/content/figures/s13063-014-0535-7-1.gif",
      "/content/figures/s13063-014-0535-7-2.gif",
      "/content/figures/s13063-014-0535-7-3.gif"
    ]
  },
  "figure_caption": {
    "value": [
      "Figure 1.",
      "The therapeutic decision-making process for patients with cancer in Brittany (France),\n            including the multidisciplinary cancer (MDC) meeting.",
      "Figure 2.",
      "Evaluation design of the multidisciplinary cancer (MDC) team’s pre-screening decisions.",
      "Figure 3.",
      "Venn diagram of the pre-screening of patients eligible for four randomized clinical\n            trials carried out at the Comprehensive Cancer Center in Rennes (GETUG 14, 15, 16,\n            and 17)."
    ]
  },
  "license": {
    "value": [
      "\r\n\t\t\t\tThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.\r\n\t\t\t"
    ]
  },
  "copyright": {
    "value": [
      "\r\n            © 2015 Campillo-Gimenez et al.; licensee BioMed Central. \r\n        "
    ]
  }
}